<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03336515</url>
  </required_header>
  <id_info>
    <org_study_id>2014142</org_study_id>
    <nct_id>NCT03336515</nct_id>
  </id_info>
  <brief_title>Validity of a Vibrating Postural Device for the Treatment of Positional Obstructive Sleep Apnea (Postural)</brief_title>
  <acronym>POSTURAL</acronym>
  <official_title>Validity of a Vibrating Postural Device for the Treatment of Positional Obstructive Sleep Apnea (Postural)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario Araba</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>SIBEL SL</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Arnau de Vilanova</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto de Salud Carlos III</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto Vasco de Investigación Sanitaria (BIOEF)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Universitario Araba</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is validity of the effectiveness of a vibrating postural device in
      reduce the respiratory events (Apnea-Hypopnea Index-AHI) in patients with positional
      Obstructive Sleep Apnea (OSA).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PURPOSE:

      The objective of the study is validity of the effectiveness of a vibrating postural device in
      reduce the respiratory events (Apnea-Hypopnea Index-AHI) in patients with positional
      Obstructive Sleep Apnea (OSA).

      The postural device is a vibratil device of 5x3 cm and a weight of about 30 grams integrating
      an accelerometer, a vibration and other sensors. The device is placed on the patient's
      forehead and when the device detects that the patient is in the supine position for 30
      seconds or more, it starts a vibration, with increasing intensity, which ceases when the
      patient moves to lateral.

      METHODOLOGY: DESIGN: A multicenter, randomized parallel study controlled by placebo. It will
      include patients with diagnosis of positional OSA in the Sleep Units of the Hospital
      Universitario Araba and Hospital Arnau de Vilanova de Lleida. These patients will be
      randomized to three groups: Group A: General recommendation not sleeping in supine position;
      Group B: General recommendation not sleeping in supine position and the device without any
      activation (placebo); Group C: General recommendation not sleeping in supine position and the
      device activated (intervention group).

      Patients will undergo a basal conventional polysomnography (PSG) and after 12 weeks of
      treatment. In addition all patients will be visited at 1, 4, 8 and 12 weeks.

      PRIMARY OUTCOME: Validity of the effectiveness of a vibrating postural device in reduce the
      respiratory events in patients with positional Obstructive Sleep Apnea . SECONDARY OUTCOMES:
      To determine the effectiveness of the device for: 1) To reduce the time spent in supine
      position; 2)To maintain the quantity and the quality of sleep; 3) The side effects ; 4)
      Reduction of snoring; 5) Cost-effectiveness analysis.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Apnea-Hypopnea Index (AHI)</measure>
    <time_frame>three month</time_frame>
    <description>The effectiveness of the treatment will be measured by polysomnography (PSG), comparing the results of the basal PSG with the results of the final PSG (3 month), based on the results of the apnea hypopnea index (AHI).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduce the time spent in supine position</measure>
    <time_frame>three month</time_frame>
    <description>To determine the effectiveness of the device for to reduce the time spent in supine position, measured by polysomnography, comparing the results of the basal PSG with the results of the final PSG (3 month).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maintain the quantity and the quality of sleep</measure>
    <time_frame>three month</time_frame>
    <description>To determine the effectiveness of the device for to maintain the quantity and the quality of sleep, measured by polysomnography (PSG).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
    <time_frame>three month</time_frame>
    <description>To determine the side effects.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of snoring</measure>
    <time_frame>three month</time_frame>
    <description>To determine the effectiveness of the device for the reduction of snoring, measured by polysomnography (PSG).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Epworth Sleepiness Scale</measure>
    <time_frame>at baseline and at three month of follow-up</time_frame>
    <description>The Epworth Sleepiness Scale score (the sum of 8 items score, 0-3) can range from 0 to 24. Scores of 11-24 represent increasing levels of excessive daytime sleepiness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>three month</time_frame>
    <description>Blood pressure measurements: systolic blood pressure and diastolic blood pressure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anthropometric variables (Body mass index)</measure>
    <time_frame>three month</time_frame>
    <description>Body mass index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life (EuroQOL test)</measure>
    <time_frame>at baseline and at three month of follow-up</time_frame>
    <description>Evaluate by EuroQOL test, is a standardised measure of health status. Description of the state of health in five dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression), each of wich is defined with three levels of severity, as measured by a Likert scale type(no problems, some problems and many problems or inability to activity).</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">112</enrollment>
  <condition>OSA</condition>
  <arm_group>
    <arm_group_label>Group A-General Recommendation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>General recommendation not sleeping in supine position without the postural device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B-Postural device no activated</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>General recommendation not sleeping in supine position and the postural device without any activation (placebo)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C-Postural device activated</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>General recommendation not sleeping in supine position and the postural device activated (intervention group).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Group C-Postural device activated</intervention_name>
    <description>General recommendation not sleeping in supine position and the postural device activated (intervention group).</description>
    <arm_group_label>Group C-Postural device activated</arm_group_label>
    <other_name>Intervention</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Group B-Postural device no activated</intervention_name>
    <description>General recommendation not sleeping in supine position and the postural device without any activation (placebo)</description>
    <arm_group_label>Group B-Postural device no activated</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Group A-General Recommendation</intervention_name>
    <description>General recommendation not sleeping in supine position</description>
    <arm_group_label>Group A-General Recommendation</arm_group_label>
    <other_name>Control</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women ≥ 18 years old with diagnosis of positional OSA by PSG.

          -  Apnea-Hypopnea index (AHI) &gt;10

          -  Apnea-Hypopnea index (AHI) in supine position doubling AHI in not supine position

          -  Time in supine position ≥ 20% total sleep time.

          -  Total sleep time at least 180 minutes

          -  Not received any treatment for OSA in the last four weeks before inclusion at the
             study (Except hygienic measures)

          -  Written informed consent signed.

        Exclusion Criteria:

          -  Important problems of physical mobility

          -  Body mass index &gt; 40kg/m²

          -  Presence of any previously diagnosed sleep disorders (narcolepsy, insomnia...) or
             difficulty in adopting a standard sleeping position

          -  Cognitive impairment, professional driver, use dangerous machinery, workers in three
             shifts, pregnant women or patients with severe disease.

          -  Patients with severe cardiovascular and/or respiratory comorbidity

          -  Excessive daytime sleepiness, Epworth scale &gt;12

          -  Treatment with psychotropic drugs, central stimulant drugs, antidepressants, consumers
             of illegal drugs or consume &gt; 80 grams of ethanol per day.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joaquin Duran-Cantolla, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Araba</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jordi Rigau, Ing</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sibel SA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario Araba</name>
      <address>
        <city>Gasteiz / Vitoria</city>
        <state>Araba</state>
        <zip>01009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Durán J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):685-9.</citation>
    <PMID>11254524</PMID>
  </reference>
  <reference>
    <citation>Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993 Apr 29;328(17):1230-5.</citation>
    <PMID>8464434</PMID>
  </reference>
  <reference>
    <citation>Durán-Cantolla J, Mar J, de La Torre Muñecas G, Rubio Aramendi R, Guerra L. [The availability in Spanish public hospitals of resources for diagnosing and treating sleep apnea-hypopnea syndrome]. Arch Bronconeumol. 2004 Jun;40(6):259-67. Spanish.</citation>
    <PMID>15161592</PMID>
  </reference>
  <reference>
    <citation>Cartwright RD. Effect of sleep position on sleep apnea severity. Sleep. 1984;7(2):110-4.</citation>
    <PMID>6740055</PMID>
  </reference>
  <reference>
    <citation>Oksenberg A, Silverberg DS, Arons E, Radwan H. Positional vs nonpositional obstructive sleep apnea patients: anthropomorphic, nocturnal polysomnographic, and multiple sleep latency test data. Chest. 1997 Sep;112(3):629-39.</citation>
    <PMID>9315794</PMID>
  </reference>
  <reference>
    <citation>Cartwright RD, Lloyd S, Lilie J, Kravitz H. Sleep position training as treatment for sleep apnea syndrome: a preliminary study. Sleep. 1985;8(2):87-94.</citation>
    <PMID>4012159</PMID>
  </reference>
  <reference>
    <citation>Jokic R, Klimaszewski A, Crossley M, Sridhar G, Fitzpatrick MF. Positional treatment vs continuous positive airway pressure in patients with positional obstructive sleep apnea syndrome. Chest. 1999 Mar;115(3):771-81.</citation>
    <PMID>10084491</PMID>
  </reference>
  <reference>
    <citation>van Maanen JP, Richard W, Van Kesteren ER, Ravesloot MJ, Laman DM, Hilgevoord AA, de Vries N. Evaluation of a new simple treatment for positional sleep apnoea patients. J Sleep Res. 2012 Jun;21(3):322-9. doi: 10.1111/j.1365-2869.2011.00974.x. Epub 2011 Oct 22.</citation>
    <PMID>22017727</PMID>
  </reference>
  <reference>
    <citation>Ravesloot MJ, van Maanen JP, Dun L, de Vries N. The undervalued potential of positional therapy in position-dependent snoring and obstructive sleep apnea-a review of the literature. Sleep Breath. 2013 Mar;17(1):39-49. doi: 10.1007/s11325-012-0683-5. Epub 2012 Mar 24. Review.</citation>
    <PMID>22441662</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 1, 2015</study_first_submitted>
  <study_first_submitted_qc>November 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2017</study_first_posted>
  <last_update_submitted>January 5, 2018</last_update_submitted>
  <last_update_submitted_qc>January 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario Araba</investigator_affiliation>
    <investigator_full_name>Joaquin Duran-Cantolla, MD</investigator_full_name>
    <investigator_title>Principal Investigator. MD,PhD</investigator_title>
  </responsible_party>
  <keyword>Positional Obstructive Sleep Apnea</keyword>
  <keyword>Postural Device</keyword>
  <keyword>Treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

